Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

Clinical trial NCT04781322 · RECRUITING

Trial details

NCT number: NCT04781322
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Associated Liver Disease Heavy Drinking Behavior

Start date: 2021-10-19
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.